Optimized Viral Dose and Transient Immunosuppression Enable Herpes Simplex Virus ICP0-Null Mutants To Establish Wild-Type Levels of Latency In Vivo
The reduced efficiency with which herpes simplex virus type 1 (HSV-1) mutants establish latent infections in vivo has been a fundamental obstacle in efforts to determine the roles of individual viral genes in HSV-1 reactivation. For example, in the absence of the “nonessential” viral immediate-early...
Zapisane w:
| Wydane w: | J Virol |
|---|---|
| Główni autorzy: | , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
American Society for Microbiology (ASM)
2000
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC112092/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10846077/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.74.13.5957-5967.2000 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|